FDA to revoke approvals for three of four arsenic-containing animal drugs

摘要

Only one arsenic-containing animal drug is left in the U.S. market --nitarsone -- after FDA notified two consumer groups, Sept. 30, that drug companies have asked the agency to withdraw approval for the remaining animal drugs.